Broad Arrow Auctions, a Hagerty (NYSE: HGTY) company, has released the complete digital catalog for its upcoming third annual Amelia Auction, set for March 7-8, 2025, at The Ritz-Carlton Amelia Island ...

The updates impacted the companies' stock prices in early January ... a key plank of his economic platform and has threatened tariffs on foreign-made cars," Bloomberg wrote.

Welcome to automotive royalty. Once you’re talking about the best cars over $300k, you can expect unsurpassed standards of design, craftsmanship, performance, and prestige. Some of the cars here ...

Insuring your car can be a big expense. But the right car insurance company can save you hundreds a year in premiums, score you a lower deductible and even get you a hefty discount. CNBC Select ...

While her extensive car collection includes a lot of the usual suspects, there are also some absolute bangers in there, like a restomod '67 Ford Bronco, a murdered-out third-generation El Camino ...

League of Legends is an old game. Like, really old. Old enough to be in high school, even. But players are fed up with its old and archaic systems, and are now begging Riot to introduce an ...

Automatic Data Processing is a Dividend King whose future dividend growth prospects remain promising. The company's revenue and adjusted diluted EPS climbed higher in its fiscal Q2. ADP boasts an ...

Legend Power Systems Inc., together with its subsidiaries, provides onsite energy management technology in Canada and the United States. The company assembles, markets, and sells SmartGATE, a ...

We reviewed the best free Adobe Illustrator alternatives for managing graphics files without a Creative Cloud subscription. We've rounded-up our top-rated choices for when you want to make the ...

Legend Biotech Corporation (NASDAQ:LEGN), with a market capitalization of $6.74 billion, has emerged as a prominent player in the biotechnology sector, primarily due to the success of its flagship ...

Legend Biotech's ambitious manufacturing expansion plans are crucial to meeting the growing demand for Carvykti. However, scaling up production of complex cell therapies like CAR-T presents ...